Entry price: 237.96
Fundamentals:
- Sector: Medical - Biotech
- EPS % Chg (Last Qtr): 123%
- EPS % Chg (Previous Qtr): 86%
- 3 Year EPS Growth Rate: 25%
- EPS Est % Chg (Current Yr): 28%
- Sales % Chg (Last Qtr): 25%
- Sales % Chg (Previous Qtr): 22%
- 3-Year Sales Growth Rate: 16%
- Annual Pre -Tax Margin: 24.9%